+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Complete remission of multiple brain metastases of non-small cell lung cancer induced by gefitinib monotherapy



Complete remission of multiple brain metastases of non-small cell lung cancer induced by gefitinib monotherapy



Strahlentherapie und Onkologie 187(12): 826-830



While the activity of tyrosine kinase inhibitors as the first line treatment for primary tumors in patients with stage IV non-small cell lung cancer and a positive EGF receptor mutation is well known, little data on the efficacy in controlling cerebral metastases are available. A 43-year-old woman was diagnosed with non-small cell lung cancer with cerebral and hepatic metastases. Emergency radiation therapy was initiated at the time of diagnosis due to superior vena cava syndrome. However, after she failed to respond to this therapy and in light of a positive EGF receptor mutation, gefitinib was added at a dose of 250 mg/day while continuing radiation to the primary lesion and cervical lymph nodes. She showed a rapid clinical and radiologic response with complete remission of the cerebral metastases 6 weeks after starting gefitinib. No severe toxicity was observed. This case demonstrates that gefitinib can be given during radiation treatment without significant toxicity. Furthermore, complete remission of cerebral metastases can be achieved with tyrosine kinase inhibitor monotherapy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052260110

Download citation: RISBibTeXText

PMID: 22127359

DOI: 10.1007/s00066-011-2260-4


Related references

Complete metabolic remission with Gefitinib in a hemodialysis patient with bone metastases from non-small cell lung cancer. Anticancer Research 34(1): 319-322, 2014

Comparison of Gefitinib versus VMP in the combination with radiotherapy for multiple brain metastases from non-small cell lung cancer. Cell Biochemistry and Biophysics 71(2): 1261-1265, 2015

Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission. Cochrane Database of Systematic Reviews: Cd002805-Cd002805, 2000

Brain metastases in patients with limited small cell lung cancer achieving complete remission. Correlation with TNM staging. Chest 96(6): 1332-1335, 1989

A case of long-term remission of small-cell lung cancer with multiple brain metastases. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(7): 1159-1162, 2011

A case of renal cell carcinoma with multiple lung metastases refractory to interferon-alpha showing complete remission by interleukin-2 monotherapy. International Journal of Urology 13(6): 805-808, 2006

Complete Remission of Brain Metastases in Non-Small Cell Lung Cancer Patients Harboring an EGFR Mutation Treated with Tyrosine Kinase Inhibitor without Radiotherapy: A Report of 3 Cases. Case Reports in Oncology 7(1): 149-154, 2014

Effect of gefitinib on brain metastases from non-small cell lung cancer. Neurologia Medico-Chirurgica 46(10): 504-507, 2006

Prevalence of brain metastases immediately before prophylactic cranial irradiation in limited disease small cell lung cancer patients with complete remission to chemoradiotherapy: a single institution experience. Journal of Thoracic Oncology 3(6): 652-655, 2008

Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy. Oncotarget 6(10): 8366-8376, 2015

Gefitinib as a first line of therapy in non-small cell lung cancer with brain metastases. Internal Medicine 43(8): 718-720, 2004

Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis. Biomed Research International 2016: 5807346, 2016

Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial. Annals of Oncology 15(7): 1042-1047, 2004

Evaluation of gefitinib plus radiotherapy in non-small-cell lung cancer patients with brain metastases. Zhonghua Yi Xue Za Zhi 92(8): 524-527, 2012

Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases. Clinical Lung Cancer 6(2): 123-128, 2004